Aligos Therapeutics, Inc.

Q1 2023 13F Holders

Symbol
ALGS
CUSIP
01626L105
Type
Equity
Class
COM
Num filings
49
Total reported value, excl. options
$23.9 M
Manager Report Date Value ($000) Shares Option Type